Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

August 31, 2004

Conditions
Breast CancerInfertilityMenopausal Symptoms
Interventions
DRUG

cyclophosphamide

DRUG

goserelin acetate

PROCEDURE

adjuvant therapy

PROCEDURE

fertility assessment and management

PROCEDURE

neoadjuvant therapy

Trial Locations (66)

RG24 9NA

Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke

BA1 3NG

Royal United Hospital, Bath

BS16 1LE

Frenchay Hospital, Bristol

CB2 2QQ

Addenbrooke's Hospital, Cambridge

WA7 2DA

Halton Hospital, Cheshire

C03 3NB

Essex County Hospital, Colchester

DT1 2JY

Dorset County Hospital, Dorchester

DY1 2HQ

Russells Hall Hospital, Dudley

NE9 6SX

Queen Elizabeth Hospital, Gateshead

DN33 2BA

Diana Princess of Wales Hospital, Grimsby

NW3 2QG

UCL Cancer Institute, Hampstead, London

HD3 3EA

Huddersfield Royal Infirmary, Huddersfield, West Yorks

IG3 8YB

King George Hospital, Ilford, Essex

IP4 5PD

Ipswich Hospital, Ipswich

DY11 6RJ

Kidderminster Hospital, Kidderminster Worcestershire

LS16 6QB

Yorkshire Regional Clinical Trials & Research Unit, Leeds

L7 8XP

Royal Liverpool University Hospital, Liverpool

E11 1NR

Whipps Cross Hospital, London

E13 85L

Newham University Hospital, London

E9 6SR

Homerton University Hospital, London

EC1A 7BE

Saint Bartholomew's Hospital, London

N18 1QX

Helen Rollason Cancer Care Centre at North Middlesex Hospital, London

N19 5NF

Whittington Hospital, London

SE1 9RT

Guy's Hospital, London

SW17 0QT

St. George's Hospital, London

W6 8RF

Charing Cross Hospital, London

LU4 0DZ

Luton and Dunstable Hospital, Luton-Bedfordshire

ME16 9QQ

Maidstone Hospital, Maidstone

M20 4BX

Christie Hospital, Manchester

M8 6RB

North Manchester General Hospital - Penine Actute Hospitals Trust, Manchester

CH63 4JY

Clatterbridge Centre for Oncology, Merseyside

HA6 2RN

Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood

NR4 7UY

Norfolk and Norwich University Hospital, Norwich

PE3 6DA

Peterborough Hospitals Trust, Peterborough

BH15 2JB

Dorset Cancer Centre, Poole Dorset

PO3 6AD

Portsmouth Oncology Centre at Saint Mary's Hospital, Portsmouth Hants

RM7 OBE

Oldchurch Hospital, Romford

SP2 8BJ

Salisbury District Hospital, Salisbury

DN15 7BH

Scunthorpe General Hospital, Scunthorpe

S1O 2SJ

Cancer Research Centre at Weston Park Hospital, Sheffield

SO16 6YD

Southampton General Hospital, Southampton

TR1 3LJ

Royal Cornwall Hospital, Truro, Cornwall

TN4 8AT

Kent and Sussex Hospital, Tunbridge Wells, Kent

WA5 1QG

Warrington Hospital NHS Trust, Warrington

SS0 0RY

Southend University Hospital NHS Foundation Trust, Westcliff-on-Sea

WV10 0QP

New Cross Hospital, Wolverhampton

BA21 4AT

Yeovil District Hospital, Yeovil - Somerset

AB25 2ZN

Aberdeen Royal Infirmary, Aberdeen

DG1 4AP

Dumfries & Galloway Royal Infirmary, Dumfries

DD1 9SY

Ninewells Hospital, Dundee

KY12 0SU

Queen Margaret Hospital - Dunfermline, Dunfermline

EH4 2XU

Edinburgh Cancer Centre at Western General Hospital, Edinburgh

FK1 5QE

Falkirk and District Royal Infirmary, Falkirk

G11 6NT

Beatson West of Scotland Cancer Centre, Glasgow

G4 0SF

Royal Infirmary - Castle, Glasgow

G51 4TF

Southern General Hospital, Glasgow

1V2 3UJ

Raigmore Hospital, Inverness

KA2 OBE

Crosshouse Hospital, Kilmarnock

Unknown

Royal Alexandra Hospital, Paisley

SY23 1ER

Bronglais District General Hospital, Aberystwyth

LL57 2PW

Ysbyty Gwynedd, Bangor

CF14 2TL

Velindre Cancer Center at Velindre Hospital, Cardiff

SA61 2PZ

Withybush General Hospital, Haverfordwest

CF72 8XR

Royal Glamorgan Hospital, Lhantrisant

LL 18 5UJ

Glan Clwyd Hospital, Rhyl, Denbighshire

SA2 8QA

South West Wales Cancer Institute, Swansea

All Listed Sponsors
lead

Anglo Celtic Cooperative Oncology Group

OTHER

NCT00427245 - Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer | Biotech Hunter | Biotech Hunter